Klaus Dugi

Klaus Dugi

Executive Vice President and Chief Medical Officer

Klaus joined Ferring in October 2017. He is responsible for Global Medical Affairs, Quality Assurance and Pharmacovigilance.

Prior to joining Ferring, Klaus held various leadership roles at Boehringer Ingelheim, including Vice President Global Medical Affairs, Chief Medical Officer, and, most recently, Managing Director UK & Ireland.

A Professor of Medicine, with a specialty in Internal Medicine, Klaus continues to teach medicine at Heidelberg University, Germany. He also spent four years carrying out research at the US National Institutes of Health (NIH) and has published more than 70 manuscripts in peer-reviewed journals including The Lancet and Diabetes.